Literature DB >> 25413984

The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations.

A K Gupta1,2, D Daigle2, K A Foley2.   

Abstract

Onychomycosis is a fungal infection of the nail and is the most common nail affliction in the general population. Certain patient populations are at greater risk of infection and the prevalence of onychomycosis reported in the literature has yet to be summarized across these at-risk groups. We performed a systematic review of the literature and calculated pooled prevalence estimates of onychomycosis in at-risk patient populations. The prevalence of dermatophyte toenail onychomycosis was as follows: general population 3.22% (3.07, 3.38), children 0.14% (0.11, 0.18), the elderly 10.28% (8.63, 12.18), diabetic patients 8.75% (7.48, 10.21), psoriatic patients 10.22% (8.61, 12.09), HIV positive patients 10.40% (8.02, 13.38), dialysis patients 11.93% (7.11, 19.35) and renal transplant patients 5.17% (1.77, 14.14). Dialysis patients had the highest prevalence of onychomycosis caused by dermatophytes, elderly individuals had the highest prevalence of onychomycosis caused by yeasts (6.07%; 95% CI = 3.58, 10.11) and psoriatic patients had the highest prevalence of onychomycosis caused by non-dermatophyte moulds (2.49%; 95% CI = 1.74, 3.55). An increased prevalence of onychomycosis in certain patient populations may be attributed to impaired immunity, reduced peripheral circulation and alterations to the nail plate which render these patients more susceptible to infection.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2014        PMID: 25413984     DOI: 10.1111/jdv.12873

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

Review 1.  Network Meta-Analysis of Onychomycosis Treatments.

Authors:  Aditya K Gupta; Deanne Daigle; Kelly A Foley
Journal:  Skin Appendage Disord       Date:  2015-06-26

2.  Opacity of big toenail predicts poor prognosis in patients with end-stage renal disease on hemodialysis.

Authors:  Osamu Soma; Shingo Hatakeyama; Teppei Matsumoto; Toshikazu Tanaka; Yoshimi Tanaka; Shogo Hosogoe; Hirotake Kodama; Hirotaka Horiguchi; Yuka Kubota; Koichi Kido; Masaki Momota; Go Anan; Ikuyo Narita; Ryuji Kitahara; Hisao Saitoh; Tadashi Suzuki; Chikara Ohyama
Journal:  Clin Exp Nephrol       Date:  2017-10-25       Impact factor: 2.801

3.  Evaluation of relationships between onychomycosis and vascular diseases using sequential pattern mining.

Authors:  Chul Hwan Bang; Jae Woong Yoon; Hyun Ji Lee; Jun Young Lee; Young Min Park; Suk Jun Lee; Ji Hyun Lee
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

4.  Nail Dystrophy in Patients with Atopic Dermatitis and Its Association with Disease Severity.

Authors:  Bo Young Chung; Yong Won Choi; Hye One Kim; Chun Wook Park
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

Review 5.  Fungal Infections and Nail Psoriasis: An Update.

Authors:  Aikaterini Kyriakou; Sofia-Chrysovalantou Zagalioti; Myrto-Georgia Trakatelli; Christina Fotiadou; Zoe Apalla; Elizabeth Lazaridou; Aikaterini Patsatsi
Journal:  J Fungi (Basel)       Date:  2022-02-03

6.  Onychomycosis: Recommendations for Diagnosis, Assessment of Treatment Efficacy, and Specialist Referral. The CONSONANCE Consensus Project.

Authors:  Bianca Maria Piraccini; Michela Starace; Adam I Rubin; Nilton Gioia Di Chiacchio; Matilde Iorizzo; Dimitris Rigopoulos
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-09

7.  Combined laser and ozone therapy for onychomycosis in an in vitro and ex vivo model.

Authors:  Javier Fernández; Iván Del Valle Fernández; Claudio J Villar; Felipe Lombó
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

8.  Towards a Standardized Procedure for the Production of Infective Spores to Study the Pathogenesis of Dermatophytosis.

Authors:  Emilie Faway; Cindy Staerck; Célya Danzelle; Sophie Vroomen; Christel Courtain; Bernard Mignon; Yves Poumay
Journal:  J Fungi (Basel)       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.